# US 2003/0082249 A1 · Compositions containing capsaicin and its derivatives, and their use in treating mucositis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0082249 A1
- Document ID: US20030082249A1
- Status: Published application
- Kind: A1
- Application number: 10/004,216
- Filed: 2001-10-26
- Published: 2003-05-01
- Earliest claimed: 2001-10-26
- Assignees: Ovation Pharmaceuticals
- Inventors: Gary Gordon
- Web page: https://patentgrep.com/patent/US20030082249A1

## CPC

- A61K 31/16: Amides, e.g. hydroxamic acids
- A61K 36/81: Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/0058: {Chewing gums (non-medicinal aspects, preparing chewing gum A23G4/00; chewing gum for care of the teeth or oral cavity, e.g. with breath freshener A61Q11/00)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A composition for use in treating or preventing mucositis, and/or xerostomia, including capsaicin or capsaicin derivative, and one or more additional compounds useful in treating mucositis and/or xerostomia, wherein the composition is provided in an oral delivery vehicle. The invention also relates to a method of treating or preventing mucositis and/or xerostomia, and a method for preparing such a composition.

## Claims

### Claim 1

A composition for use in treating mucositis, comprising:
capsaicin or capsaicin derivative; and
one or more additional compounds useful in treating mucositis, wherein the composition is provided in an oral delivery vehicle.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the capsaicin derivative is selected from the group consisting of cis-capsaicin (civamide), N-phenylmethylalkenamide capsaicin derivatives, dihydrocapsaicin, norhydrocapsaicin, homocapsaicin, homohydrocapsaicin, civamide, nonivamide, olvanil, N-[(4-(2-aminoethoxy)-3-methoxyphenyl)methyl]-9Zoctadecanamide, N-oleyl-homovanillamide, and their analogs and derivatives.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the capsaicin or capsaicin derivative is present in an amount of from about 0.01% to about 2.5% by weight.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the one or more additional compounds are selected from the group consisting of antifungal compounds, antibacterial compounds, antiviral compounds, anesthetic compounds, analgesic compounds, anti-inflammatory compounds, cytoprotective compounds, anti-histamine compounds, anti-mucositic compounds, cell differentiating agents, and anti-xerostomic compounds.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the oral delivery vehicle is selected from the group consisting of lozenges, chewing gums, other candies, creams, gels, and sprays.

### Claim 6

A method for treating mucositis, comprising the steps of:
a) administering to a patient a therapeutically effective amount of a composition comprising:
i) a capsaicin or capsaicin derivative; and
ii) one or more additional compounds useful in treating mucositis, and
b) repeating administration as necessary to relieve the mucositis.

### Claim 7 (depends on 6)

The method of claim 6, wherein the capsaicin derivative is selected from the group consisting of cis-capsaicin (civamide), N-phenylmethylalkenamide capsaicin derivatives, dihydrocapsaicin, norhydrocapsaicin, homocalpsaicin, homohydrocapsaicin, civamide, nonivamide, olvanil, N-[(4-(2-aminoethoxy)-3-methoxyphenyl)methyl]-9Z-octadecanamide, N-oleyl-homovanillamide, and their analogs and derivatives.

### Claim 8 (depends on 6)

The method of claim 6, wherein the composition is administered using a delivery system selected from the group consisting of lozenges, chewing gums, creams, gels, and sprays.

### Claim 9 (depends on 6)

The method of claim 6, wherein the one or more additional compounds are selected from the group consisting of antifungal compounds, antibacterial compounds, antiviral compounds, anesthetic compounds, analgesic compounds, anti-inflammatory compounds, cytoprotective compounds, anti-histamine compounds, anti-mucositic compounds, and anti-xerostomic compounds.

### Claim 10 (depends on 6)

The method of claim 6, wherein the composition is suitable for application to oral mucous membranes.

### Claim 11 (depends on 6)

The method of claim 6, wherein the composition is administered to a mammal.

### Claim 12 (depends on 11)

The method of claim 11, wherein the mammal is a human being.

### Claim 13

A method for preparing a composition for use in treating mucositis, comprising the steps of:
a) providing a compound comprising
i) capsaicin or a capsaicin derivative; and
ii) one or more additional compounds selected from the group consisting of antifungal compounds, antibacterial compounds, antiviral compounds, anesthetic compounds, analgesic compounds, anti-inflammatory compounds, cytoprotective compounds, anti-histaminic compounds, anti-mucositic compounds, and anti-xerostomic compounds; and
b) combining said compound with an oral delivery system, thereby forming an oral preparation.
